Nilay Thakar
InvestorPrincipal at ARCH Venture Partners
United States
Writes $50K β $150M checks Β· typically $25M
Experience
- ARCH Venture PartnersPrincipalcurrent2017 β presentBoston, Massachusetts, United States
- Skylark BioCo-Founder and Head of BDcurrent2021 β presentCambridge, Massachusetts, United States
- Lifordi Immunotherapeutics, Inc.Board Observercurrent2023 β present
- Arbor BiotechnologiesBoard Observercurrent2021 β presentBoston, Massachusetts, United States
- Volastra TherapeuticsBoard Observercurrent2022 β present
- SonoTheraBoard Observercurrent2022 β present
- Doppler BioBoard Observer2023 β 2025
- hC Bioscience, Inc.Board Observer2022 β 2025
- International Society for Stem Cell ResearchCommittee Member - Industry2019 β 2023
- Australian Institute for Bioengineering and Nanotechnology AIBNGeneral Manager - Stem Cells Ltd2014 β 2016Greater Brisbane Area
- The Australian Academy of ScienceAdvisor - Theo Murphy High Flyers Think Tank2015 β 2016
- Dendright Pty LimitedCommercialization Analyst Intern2013Greater Brisbane Area
Education
- The University of Chicago Booth School of BusinessMaster of Business Administration (M.B.A.)
- The University of QueenslandDoctor of Philosophy (Ph.D.), Stem Cell Biology
- The University of QueenslandBachelor of Science Honours Class 1, Biochemistry
Skills & more
Languages English Β· Gujarati Β· Hindi
From Nilay's professional profile.
Same school
Also attended The University of Chicago Booth School of Business431
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech CapitalRavi RajamonyVice President at March Capital Partners
+ 425 more
Also attended The University of Queensland88
Giuseppe IademarcoHead of Global Partnership at P101 VenturesJasmine BettesInvestor at Reinventure GroupEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementZenetta BurgerPartner at Giant Ventures Global LlpCherie ChouHead of Corporate Development at TNBAuraBarbara SavageAnalyst at Balerion Space Ventures
+ 82 more
Shared employers
Also worked at Lifordi Immunotherapeutics, Inc.1
Also worked at Arbor Biotechnologies2
Colleagues at ARCH Venture Partners
Ari Nowacek
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Carol Suh
Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
David Moore
Senior Partner at ARCH Venture Partners
George Scangos
Venture Partner at ARCH Venture Partners




















